Search Results

There are 2996188 results for: content related to: Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing–remitting multiple sclerosis

  1. Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis

    European Handbook of Neurological Management, Second Edition, Volume 1, Second Edition

    P. Soelberg Sørensen, F. Deisenhammer, P. Duda, R. Hohlfeld, K.-M. Myhr, J. Palace, C. Polman, C. Pozzilli, C. Ross, Pages: 63–74, 2010

    Published Online : 6 SEP 2010, DOI: 10.1002/9781444328394.ch5

  2. You have free access to this content
    Guidelines on use of anti-IFN-β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-β antibodies in multiple sclerosis

    European Journal of Neurology

    Volume 12, Issue 11, November 2005, Pages: 817–827, P. S. Sørensen, F. Deisenhammer, P. Duda, R. Hohlfeld, K.-M. Myhr, J. Palace, C. Polman, C. Pozzilli, C. Ross and for the EFNS Task Force on Anti-IFN-β Antibodies in Multiple Sclerosis

    Article first published online : 20 OCT 2005, DOI: 10.1111/j.1468-1331.2005.01386.x

  3. Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis

    European Handbook of Neurological Management

    P. Soelberg Sørensen, F. Deisenhammer, P. Duda, R. Hohlfeld, K.-M. Myhr, J. Palace, C. Polman, C. Pozzilli, C. Ross, Pages: 72–86, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753279.ch8

  4. You have free access to this content
    A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis

    Journal of Clinical Pharmacy and Therapeutics

    Volume 38, Issue 6, December 2013, Pages: 433–439, G. M. Hadjigeorgiou, C. Doxani, M. Miligkos, P. Ziakas, G. Bakalos, D. Papadimitriou, T. Mprotsis, N. Grigoriadis and E. Zintzaras

    Article first published online : 20 AUG 2013, DOI: 10.1111/jcpt.12090

  5. You have free access to this content
    Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Graziella Filippini, Cinzia Del Giovane, Laura Vacchi, Roberto D'Amico, Carlo Di Pietrantonj, Deirdre Beecher and Georgia Salanti

    Published Online : 6 JUN 2013, DOI: 10.1002/14651858.CD008933.pub2

  6. Immunogenicity of recombinant human interferon beta interacting with particles of glass, metal, and polystyrene

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 1, January 2012, Pages: 187–199, Miranda M. C. Van Beers, Francesca Gilli, Huub Schellekens, Theodore W. Randolph and Wim Jiskoot

    Article first published online : 14 SEP 2011, DOI: 10.1002/jps.22744

  7. Multiple Sclerosis

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt081

  8. Frequency and severity of headache is worsened by Interferon-β therapy in patients with multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 125, Issue 2, February 2012, Pages: 91–95, F. Patti, A. Nicoletti, A. Pappalardo, A. Castiglione, S. Lo Fermo, S. Messina, E. D’Amico, V. Cimino and M. Zappia

    Article first published online : 8 JUN 2011, DOI: 10.1111/j.1600-0404.2011.01532.x

  9. You have free access to this content
    The role of interferon beta in multiple sclerosis management

    Future Prescriber

    Volume 7, Issue 3, July/September 2006, Pages: 15–19, David J Rog and John P Mottershead

    Article first published online : 8 AUG 2008, DOI: 10.1002/fps.26

  10. Formulation and Stability of Cytokine Therapeutics

    Journal of Pharmaceutical Sciences

    Tiina Lipiäinen, Marikki Peltoniemi, Sanjay Sarkhel, Teijo Yrjönen, Heikki Vuorela, Arto Urtti and Anne Juppo

    Article first published online : 9 DEC 2014, DOI: 10.1002/jps.24243

  11. Interferon beta for secondary progressive multiple sclerosis

    Intervention Review

    The Cochrane Library

    Loredana La Mantia, Laura Vacchi, Carlo Di Pietrantonj, George Ebers, Marco Rovaris, Sten Fredrikson and Graziella Filippini

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD005181.pub3

  12. Using measurements of neutralizing antibodies: the challenge of IFN-β therapy

    European Journal of Neurology

    Volume 14, Issue 8, August 2007, Pages: 850–859, D. Hesse and P. S. Sørensen

    Article first published online : 25 JUL 2007, DOI: 10.1111/j.1468-1331.2007.01769.x

  13. Twenty-four-month comparison of immunomodulatory treatments – a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone®)

    European Journal of Neurology

    Volume 12, Issue 6, June 2005, Pages: 425–431, J. Haas and M. Firzlaff

    Article first published online : 9 MAY 2005, DOI: 10.1111/j.1468-1331.2005.00936.x

  14. Recombinant human interferon beta in relapsing–remitting multiple sclerosis: a review of the major clinical trials

    European Journal of Neurology

    Volume 7, Issue 4, July 2000, Pages: 369–380, M. Chofflon

    Article first published online : 15 JAN 2010, DOI: 10.1046/j.1468-1331.2000.00057.x

  15. You have free access to this content
    Current and future disease-modifying therapies in multiple sclerosis

    International Journal of Clinical Practice

    Volume 64, Issue 5, April 2010, Pages: 637–650, S. Y. Lim and C. S. Constantinescu

    Article first published online : 10 MAR 2010, DOI: 10.1111/j.1742-1241.2009.02261.x

  16. You have free access to this content
    Guidelines on use of anti-IFN-B antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-B antibodies in multiple sclerosis

    European Journal of Neurology

    Volume 14, Issue 6, June 2007, Pages: e8–e9, J. S. Burks and A. Noronha

    Article first published online : 29 MAY 2007, DOI: 10.1111/j.1468-1331.2007.01782.x

  17. Makromolekulare Immunsuppressiva: Proteinogene Wirkstoffe

    Pharmazie in unserer Zeit

    Volume 34, Issue 4, Juli 2005, Pages: 283–296, Ilse Zündorf, Angelika M. Vollmar and Theo Dingermann

    Article first published online : 30 JUN 2005, DOI: 10.1002/pauz.200500128

  18. Effects of interferon beta-1a and -1b over time: 6-year results of an observational head-to-head study

    Acta Neurologica Scandinavica

    Volume 113, Issue 4, April 2006, Pages: 241–247, F. Patti, A. Pappalardo, C. Florio, G. Politi, T. Fiorilla, E. Reggio and A. Reggio

    Article first published online : 8 MAR 2006, DOI: 10.1111/j.1600-0404.2005.00565.x

  19. The efficacy of glatiramer acetate in β-interferon-intolerant MS patients

    Acta Neurologica Scandinavica

    Volume 112, Issue 4, October 2005, Pages: 234–237, A. M. Vallittu, J. Peltoniemi, I. Elovaara, H. Kuusisto, M. Färkkilä, J. Multanen and J. P. Erälinna

    Article first published online : 2 SEP 2005, DOI: 10.1111/j.1600-0404.2005.00464.x

  20. Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis

    Intervention Review

    The Cochrane Library

    Loredana La Mantia, Carlo Di Pietrantonj, Marco Rovaris, Giulio Rigon, Serena Frau, Francesco Berardo, Anna Gandini, Anna Longobardi, Bianca Weinstock-Guttman and Alberto Vaona

    Published Online : 26 JUL 2014, DOI: 10.1002/14651858.CD009333.pub2